USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS
The use of NOT1 or NOT1 a polypeptides and polynucleotides in the design of protocols for the treatment of obesity, insulin resistance, type 2 diabetes, impaired glucose tolerance, cachexia or liposarcoma, among others, and diagnostic assays for such conditions. L'invention porte sur l'uti...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CAIRNS, WILLIAM, JOHN HOLDER, JULIE, CAROLINE PATEL, LISA |
| description | The use of NOT1 or NOT1 a polypeptides and polynucleotides in the design of protocols for the treatment of obesity, insulin resistance, type 2 diabetes, impaired glucose tolerance, cachexia or liposarcoma, among others, and diagnostic assays for such conditions.
L'invention porte sur l'utilisation de polypeptides et polynucléotides NOT1 ou NOT1A pour la conception de protocoles en vue notamment du traitement de l'obésité, de la résistance à l'insuline, du diabète de type 2, d'une mauvaise tolérance au glucose, de la cachexie, des liposarcomes, et pour l'élaboration d'essais diagnostiques. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0170254A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0170254A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0170254A93</originalsourceid><addsrcrecordid>eNrjZNAJDXZV8HdT8Aj1dfRT8PMPMVRw9HMBMxwV_IMCPICiQa7OrgEh_kHBPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPtzfwNDcwMjUxNHSmAglACRGJIU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS</title><source>esp@cenet</source><creator>CAIRNS, WILLIAM, JOHN ; HOLDER, JULIE, CAROLINE ; PATEL, LISA</creator><creatorcontrib>CAIRNS, WILLIAM, JOHN ; HOLDER, JULIE, CAROLINE ; PATEL, LISA</creatorcontrib><description>The use of NOT1 or NOT1 a polypeptides and polynucleotides in the design of protocols for the treatment of obesity, insulin resistance, type 2 diabetes, impaired glucose tolerance, cachexia or liposarcoma, among others, and diagnostic assays for such conditions.
L'invention porte sur l'utilisation de polypeptides et polynucléotides NOT1 ou NOT1A pour la conception de protocoles en vue notamment du traitement de l'obésité, de la résistance à l'insuline, du diabète de type 2, d'une mauvaise tolérance au glucose, de la cachexie, des liposarcomes, et pour l'élaboration d'essais diagnostiques.</description><edition>7</edition><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011227&DB=EPODOC&CC=WO&NR=0170254A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011227&DB=EPODOC&CC=WO&NR=0170254A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAIRNS, WILLIAM, JOHN</creatorcontrib><creatorcontrib>HOLDER, JULIE, CAROLINE</creatorcontrib><creatorcontrib>PATEL, LISA</creatorcontrib><title>USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS</title><description>The use of NOT1 or NOT1 a polypeptides and polynucleotides in the design of protocols for the treatment of obesity, insulin resistance, type 2 diabetes, impaired glucose tolerance, cachexia or liposarcoma, among others, and diagnostic assays for such conditions.
L'invention porte sur l'utilisation de polypeptides et polynucléotides NOT1 ou NOT1A pour la conception de protocoles en vue notamment du traitement de l'obésité, de la résistance à l'insuline, du diabète de type 2, d'une mauvaise tolérance au glucose, de la cachexie, des liposarcomes, et pour l'élaboration d'essais diagnostiques.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAJDXZV8HdT8Aj1dfRT8PMPMVRw9HMBMxwV_IMCPICiQa7OrgEh_kHBPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPtzfwNDcwMjUxNHSmAglACRGJIU</recordid><startdate>20011227</startdate><enddate>20011227</enddate><creator>CAIRNS, WILLIAM, JOHN</creator><creator>HOLDER, JULIE, CAROLINE</creator><creator>PATEL, LISA</creator><scope>EVB</scope></search><sort><creationdate>20011227</creationdate><title>USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS</title><author>CAIRNS, WILLIAM, JOHN ; HOLDER, JULIE, CAROLINE ; PATEL, LISA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0170254A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2001</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>CAIRNS, WILLIAM, JOHN</creatorcontrib><creatorcontrib>HOLDER, JULIE, CAROLINE</creatorcontrib><creatorcontrib>PATEL, LISA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAIRNS, WILLIAM, JOHN</au><au>HOLDER, JULIE, CAROLINE</au><au>PATEL, LISA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS</title><date>2001-12-27</date><risdate>2001</risdate><abstract>The use of NOT1 or NOT1 a polypeptides and polynucleotides in the design of protocols for the treatment of obesity, insulin resistance, type 2 diabetes, impaired glucose tolerance, cachexia or liposarcoma, among others, and diagnostic assays for such conditions.
L'invention porte sur l'utilisation de polypeptides et polynucléotides NOT1 ou NOT1A pour la conception de protocoles en vue notamment du traitement de l'obésité, de la résistance à l'insuline, du diabète de type 2, d'une mauvaise tolérance au glucose, de la cachexie, des liposarcomes, et pour l'élaboration d'essais diagnostiques.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO0170254A9 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | USE OF HUMAN NOT1 AND NOT1A ORPHAN RECEPTORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T09%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAIRNS,%20WILLIAM,%20JOHN&rft.date=2001-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0170254A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |